Jeff Schein

6.1k total citations · 2 hit papers
155 papers, 4.5k citations indexed

About

Jeff Schein is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Jeff Schein has authored 155 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Cardiology and Cardiovascular Medicine, 60 papers in Internal Medicine and 27 papers in Epidemiology. Recurrent topics in Jeff Schein's work include Atrial Fibrillation Management and Outcomes (60 papers), Venous Thromboembolism Diagnosis and Management (60 papers) and Attention Deficit Hyperactivity Disorder (19 papers). Jeff Schein is often cited by papers focused on Atrial Fibrillation Management and Outcomes (60 papers), Venous Thromboembolism Diagnosis and Management (60 papers) and Attention Deficit Hyperactivity Disorder (19 papers). Jeff Schein collaborates with scholars based in United States, Canada and Belgium. Jeff Schein's co-authors include Tito R. Mendoza, Charles S. Cleeland, San Keller, Carla Bann, Sheri Dodd, Winnie W. Nelson, Patrick Lefèbvre, François Laliberté, Concetta Crivera and S. Vallow and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Jeff Schein

148 papers receiving 4.3k citations

Hit Papers

Validity of the Brief Pain Inventory for Use in Documenti... 2004 2026 2011 2018 2004 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Schein United States 35 1.2k 1.1k 903 885 739 155 4.5k
Vincenza Snow United States 34 822 0.7× 1.9k 1.8× 235 0.3× 319 0.4× 946 1.3× 72 6.2k
Fernanda Bellolio United States 39 856 0.7× 520 0.5× 278 0.3× 398 0.4× 993 1.3× 200 5.1k
Xuemei Luo United States 29 1.0k 0.8× 942 0.9× 542 0.6× 118 0.1× 485 0.7× 112 3.3k
M. Tryba Germany 31 916 0.8× 247 0.2× 293 0.3× 1.4k 1.6× 2.0k 2.8× 156 4.6k
Samir H. Mody United States 21 549 0.5× 228 0.2× 279 0.3× 169 0.2× 556 0.8× 66 3.9k
Thiérry Ducruet Canada 34 398 0.3× 463 0.4× 297 0.3× 85 0.1× 567 0.8× 135 5.3k
Sascha Dublin United States 37 1.6k 1.3× 270 0.2× 90 0.1× 217 0.2× 447 0.6× 131 5.3k
Dan Benhamou France 50 2.1k 1.8× 286 0.3× 166 0.2× 2.2k 2.5× 5.5k 7.5× 425 9.5k
Patrick M. Reilly United States 47 716 0.6× 178 0.2× 282 0.3× 368 0.4× 2.8k 3.7× 220 6.8k
Gary M. Vilke United States 47 541 0.5× 197 0.2× 66 0.1× 1.1k 1.2× 1.3k 1.7× 309 6.7k

Countries citing papers authored by Jeff Schein

Since Specialization
Citations

This map shows the geographic impact of Jeff Schein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Schein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Schein more than expected).

Fields of papers citing papers by Jeff Schein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Schein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Schein. The network helps show where Jeff Schein may publish in the future.

Co-authorship network of co-authors of Jeff Schein

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Schein. A scholar is included among the top collaborators of Jeff Schein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Schein. Jeff Schein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grossberg, George T., Cynthia Willey, Christy R. Houle, et al.. (2025). Agitation in individuals with Alzheimer’s disease: An assessment of behaviors using the cohen-mansfield agitation inventory in community-dwellers and impact on caregiver experience. Dementia. 25(2). 421–442. 1 indexed citations
4.
Schein, Jeff, et al.. (2024). Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder. Journal of Medical Economics. 27(1). 653–662.
5.
Schein, Jeff, et al.. (2024). Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder – A Discrete Choice Experiment. Patient Preference and Adherence. Volume 18. 1651–1664. 3 indexed citations
7.
Grossberg, George T., Annette Urganus, Jeff Schein, et al.. (2023). A real-world assessment of healthcare costs associated with agitation in Alzheimer’s dementia. Journal of Medical Economics. 27(1). 99–108. 5 indexed citations
8.
Schein, Jeff, et al.. (2022). Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study. Advances in Therapy. 39(12). 5487–5503. 9 indexed citations
9.
Schein, Jeff, Christy R. Houle, Annette Urganus, et al.. (2022). The Impact of Agitation in Dementia on Caregivers: A Real-World Survey. Journal of Alzheimer s Disease. 88(2). 663–677. 15 indexed citations
10.
Schein, Jeff, Ann Childress, Martin Cloutier, et al.. (2022). Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study. BMC Psychiatry. 22(1). 377–377. 15 indexed citations
11.
Peacock, W. Frank, Craig I Coleman, Philip S. Wells, et al.. (2019). Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care. Journal of health economics and outcomes research. 6(3). 160–173. 1 indexed citations
12.
Wang, Li, Onur Başer, Philip S. Wells, et al.. (2016). Abstract 13112: Benefit of Early Discharge Among Patients With Low-risk Pulmonary Embolism: Focus on Net Clinical Impact. Circulation. 134(suppl_1). 1 indexed citations
13.
Lang, Kathleen, Aarti A. Patel, Winnie W. Nelson, et al.. (2014). Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis. BMC Health Services Research. 14(1). 329–329. 25 indexed citations
14.
Chen, Shih‐Yin, Concetta Crivera, Michael B. Stokes, Luke Boulanger, & Jeff Schein. (2014). Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome. BMC Health Services Research. 14(1). 80–80. 12 indexed citations
15.
Suh, Dong‐Churl, et al.. (2013). Factors associated with warfarin discontinuation, including bleeding patterns, in atrial fibrillation patients. Current Medical Research and Opinion. 29(7). 761–771. 15 indexed citations
16.
Laliberté, François, Katherine Dea, Joyce LaMori, et al.. (2011). Abstract 9213: Risk of Gastrointestinal Conditions Among Patients with Atrial Fibrillation. Circulation. 124(suppl_21).
17.
LaMori, Joyce, H.J. Gross, Ashaben Patel, et al.. (2011). PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATION. Value in Health. 14(3). A34–A34. 2 indexed citations
18.
LaMori, Joyce, H.J. Gross, Aarti Patel, et al.. (2011). PCV14 DYSPEPSIA AND DISEASE BURDEN AMONG PATIENTS WITH ATRIAL FIBRILLATION (AF). Value in Health. 14(3). A34–A34. 1 indexed citations
19.
Harding, Gale, S. Vallow, Nancy Kline Leidy, et al.. (2007). Ease of care with patient controlled analgesia systems: questionnaire development and validation. Journal of Advanced Nursing. 59(5). 530–541. 24 indexed citations
20.
Jamison, Robert N., Jeff Schein, S. Vallow, et al.. (2003). Abtracts Diagnosis, assessment, and reviews. Journal of Pain. 4(2). 1–104. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026